Clinical Face Transplantation
Klíčová slova: Clinical Face Transplantation, Composite tissue allotransplantation, Surgical technique, Surgical Techniques for Face Transplantation, Program Ethics and Logistics for Face Transplantation
Klíčové pojmy: Indication centers on total destruction of orbicularis oris and/or orbicularis oculi., Three-part indication: defect, patient, and transplantation team., Lower-face transplants primarily address orbicularis oris loss, often from ballistic trauma., Upper-face transplants primarily address orbicularis oculi loss, commonly from burns., Screen anti-HLA antibodies every 3 months preoperatively in screened candidates., Virtual preoperative cross-match must be negative before proceeding to transplant., Acute rejection commonly occurs around 3 weeks postinduction and is typically steroid-responsive., Regular skin/mucosal biopsies and clinical exams are essential for early rejection detection., Long-term immunosuppression risks include diabetes, hypertension, renal impairment, skin cancer, and PTLD., Reinnervation rehab (physical and speech therapy) usually improves function within 3–6 months., Delay elective secondary surgeries ~6 months post-transplant and use perioperative steroids to reduce rejection risk., Psychological stability and capacity for lifelong adherence are mandatory for candidacy.
## Introduction
Face transplantation is an advanced reconstructive option for patients with severe facial defects that cannot be fully restored by conventional autologous reconstruction. The procedure aims to restore appearance and dynamic facial function, improving communication and social reintegration. Selection of candidates balances the anatomical defect with immunological and psychological factors, and requires a dedicated multidisciplinary team.
> Definition: Face transplantation is the transfer of facial tissues from a donor to a recipient to restore form and function in cases of irreparable facial destruction.
## Key concepts broken down
### 1. Types of face transplant
- **Lower-face transplant**: targets defects that destroy the orbicularis oris (mouth sphincter). Typical cause: ballistic trauma that destroys mouth and often nose; indication centers on mouth destruction.
- **Upper-face transplant**: targets defects involving the orbicularis oculi (eyelid/around-eye musculature). Common cause: severe burns with bilateral eyelid destruction. Can be combined with ear or nose elements.
- **Full face transplant**: combination of upper and lower components when both orbicularis muscles are destroyed.
> Definition: Orbicularis oris is the circular muscle around the mouth responsible for lip closure and articulation; orbicularis oculi is the circular muscle around the eye responsible for eyelid closure and blink.
### 2. Indication framework (three elements)
1. **The defect**: extent and which muscles are destroyed, especially orbicularis oris and orbicularis oculi. Consider whether autologous reconstruction can achieve function and appearance.
2. **The patient**: immunological status, psychological stability, ability to adhere to lifelong immunosuppression, motivation.
3. **The transplantation team**: expertise, rehearsal, logistics, and multidisciplinary approval.
### 3. Patient selection details
- Indications are limited: transplant should be reserved for patients with **total destruction of orbicularis muscles** (upper and/or lower). Many facial defects can be reconstructed without transplantation.
- Main etiologies: burns, ballistic trauma, animal bites, and tumors.
- Psychological contraindications: active psychiatric instability, borderline personality disorder, severe addiction, or any condition impairing informed consent and adherence to lifelong therapy.
- Presensitization (immune exposure) matters: prior cadaveric skin grafts or blood transfusions can create anti-HLA antibodies and complicate donor selection.
Did you know that presensitization to a common HLA antigen (for example HLA A2) effectively halves the pool of compatible donors if HLA A2 is present in 50% of potential donors?
### 4. Immunology and preoperative testing
- **Blood group compatibility** is required for face transplant.
- **HLA matching** is not always mandatory but becomes important when the recipient is presensitized.
- Screen for anti-HLA antibodies every 3 months during the preoperative period.
- Highly sensitive tests (e.g., Luminex) can detect antibodies that may arise from infections that mimic HLA antigens.
- A **virtual preoperative cross-match** should be negative before proceeding; a postoperative real cross-match confirms compatibility.
- In case of positive real cross-match, targeted therapies such as **anti-CD20 monoclonal antibody** plus immunoglobulin infusion may be used to prevent humoral rejection.
> Definition: Presensitization refers to prior immune exposure that leads to circulating anti-HLA antibodies, increasing the risk of antibody-mediated rejection.
### 5. Rejection patterns and long-term immunology
- **Acute rejection**: common after induction as T-lymphocyte populations recover (around 3 weeks). Presents as an erythematous rash or inflammation of graft skin/mucosa. Usually controlled with steroid boli.
- **Infection-triggered rejection**: infections can precipitate additional acute rejection episodes and n